Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2020
Identification of a RAS-activating <i>TMEM87A-RASGRF1</i> Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer
Alissa J Cooper, Yoshihisa Kobayashi, Dewey Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 18, 2018
Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
K Lance Gould, Nils P Johnson, Amanda E Roby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 28, 2023
Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma
Jia Luo, Michelle Sanchez, Elinton Lee, et al.
The Annals of Thoracic Surgery
|
December 27, 2021
Minimally Invasive Versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-Risk Patients
Mark J Russo, Vinod H Thourani, David J Cohen, et al.
Nature Communications
|
September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitis
Agnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2020
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC
Gonzalo Recondo, Magda Bahcall, Liam F Spurr, et al.
Nature Communications
|
September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors
Yoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.
The Journal of Experimental Medicine
|
May 16, 2019
Correction: A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation
Isabel Z Fernandez, Ryan M Baxter, Josselyn E Garcia-Perez, et al.
The Journal of Experimental Medicine
|
May 2, 2019
A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation
Isabel Z Fernandez, Ryan M Baxter, Josselyn E Garcia-Perez, et al.
ACS Medicinal Chemistry Letters
|
September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors
Ryan P Wurz, Liping H Pettus, Kate Ashton, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2020
Identification of a RAS-activating <i>TMEM87A-RASGRF1</i> Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer
Alissa J Cooper, Yoshihisa Kobayashi, Dewey Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 18, 2018
Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
K Lance Gould, Nils P Johnson, Amanda E Roby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 28, 2023
Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma
Jia Luo, Michelle Sanchez, Elinton Lee, et al.
The Annals of Thoracic Surgery
|
December 27, 2021
Minimally Invasive Versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-Risk Patients
Mark J Russo, Vinod H Thourani, David J Cohen, et al.
Nature Communications
|
September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitis
Agnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2020
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC
Gonzalo Recondo, Magda Bahcall, Liam F Spurr, et al.
Nature Communications
|
September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors
Yoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.
The Journal of Experimental Medicine
|
May 16, 2019
Correction: A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation
Isabel Z Fernandez, Ryan M Baxter, Josselyn E Garcia-Perez, et al.
The Journal of Experimental Medicine
|
May 2, 2019
A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation
Isabel Z Fernandez, Ryan M Baxter, Josselyn E Garcia-Perez, et al.
ACS Medicinal Chemistry Letters
|
September 24, 2015
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors
Ryan P Wurz, Liping H Pettus, Kate Ashton, et al.
Page
of 4